Oct 18 2024 This Week in Cardiology Listener feedback on the c-statistic, atherosclerotic plaque imaging, WATCHMAN implant decisions in the US, and deprescribing are the topics John Mandrola, MD, discusses in this week’s podcast. theheart.org on Medscape, October 18, 2024 2 Oct 11 202...
whether the Amplatzer Amulet left atrial appendage closure device (Abbott) could achieve comparable outcomes to the market-approved Watchman occluder (Boston Scientific) in patients with nonvalvular AF—the device received FDA approval this week based on these data, which haven’t yet been released....
The randomized multi-center open-label COMPARE LAAO trial comparing the Watchman and other LAA occlusion devices to usual care of antiplatelet therapy or nothing started recruiting in January 2021 [31]. In 2021, new evidence (LAAOS III trial) has been published regarding the benefit of surgical...